Traffic:
10E
10W
15N
15S
57N
57S
60E
60W
210E
210W
This Site
Web Search
powered by
YAHOO! SEARCH
Subscriber Services
|
Home Delivery
|
e-Edition
|
Alerts
|
RSS
Home
News
Ontario
Rancho Cucamonga
Pomona
Upland
Claremont
Montclair
Chino Valley
California
Crime & Public Safety
Elections
Education
S.B. County Watch
Upland Watch
I.E.: Medicare Testing Ground
Sports
Buy Event Tickets Now
Golf - Tee Times and Courses
Preps
Reign Hockey
Rancho Cucamonga Quakes
Local Colleges
USC
UCLA
Lakers
Clippers
Dodgers
Angels
Ducks
Soccer
Motor Sports
Horse Racing
Live Odds
Business
Autos
Real Estate News
Technology
Opinions
Editorial
Letters
Columnists
Blogs
LA.COM
Buy Tickets
Movies
TV
Music
Shopping & Beauty
Recreation
Neighborhood
Arts
Living
Dining
Find A Restaurant
Lottery
Horoscopes
Travel
Trevor's Travels
Health
Crossword Puzzle
Local Casinos
Foothills Magazine
Info
Subscribe For Home Delivery
Contact Us
RSS
Podcast
Subscriber Services
Place An Ad
NIE
Classified
Place an Ad
Homes
Jobs
Auto
Search autos
Buy/Sell a car
Research/Financing a car
Find a dealer
Shopping
This week's ads
Obits
Directories
Local Business
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Gilead Sciences
(NQ:
GILD
)
74.14
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,469
Open
74.14
Bid (Size)
74.20 (1)
Ask (Size)
74.45 (1)
Prev. Close
74.14
Today's Range
74.14 - 74.14
52wk Range
62.07 - 87.86
Shares Outstanding
1,253,809,440
Dividend Yield
4.05%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Gilead’s Livdelzi (Seladelpar) Granted Accelerated Approval for Primary Biliary Cholangitis by U.S. FDA
August 14, 2024
From
Gilead Sciences, Inc.
Via
Business Wire
7 Defensive Stocks to Buy as Investors Seek Shelter
August 14, 2024
With the market primed for more jitters, investors should consider battening down the hatches with these defensive stocks.
Via
InvestorPlace
Performance
YTD
-10.93%
-10.93%
1 Month
+4.70%
+4.70%
3 Month
+10.64%
+10.64%
6 Month
+1.51%
+1.51%
1 Year
-6.91%
-6.91%
More News
Read More
3 Stocks Retirees Should Absolutely Love
August 10, 2024
Via
The Motley Fool
Analysts Cite Improved Investor Sentiment For Gilead, But Warn of Limited Growth at Current Stock Levels
August 09, 2024
Via
Benzinga
Wall Street Momentum Stalls After Thursday's Rally, Palantir Jumps To 3-Year Highs, Bonds Rally: What's Driving Markets Friday?
August 09, 2024
Via
Benzinga
Gilead Sciences (GILD) Q2 2024 Earnings Call Transcript
August 08, 2024
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
GILD Stock Earnings: Gilead Sciences Beats EPS, Beats Revenue for Q2 2024
August 08, 2024
Via
InvestorPlace
Gilead Eyes A Breakout After Second-Quarter Sales, Earnings Beat
August 08, 2024
Via
Investor's Business Daily
Gilead Sciences Announces Second Quarter 2024 Financial Results
August 08, 2024
From
Gilead Sciences, Inc.
Via
Business Wire
Wall Street Set For Uneventful Start Ahead Of Jobless Claim Data, VIX Rises: Strategist Says Market May Remain Vulnerable Until...
August 08, 2024
Via
Benzinga
Topics
Economy
Stocks
Exposures
Economy
US Equities
Wall Street Rallies As Economic Concerns Recede, Tech Flexes Its Muscles, Semiconductors Soar: What's Driving Markets Thursday?
August 08, 2024
Via
Benzinga
$1000 Invested In Gilead Sciences 20 Years Ago Would Be Worth This Much Today
August 06, 2024
Via
Benzinga
Gilead Sciences's Options Frenzy: What You Need to Know
July 30, 2024
Via
Benzinga
$100 Invested In Gilead Sciences 20 Years Ago Would Be Worth This Much Today
July 29, 2024
Via
Benzinga
This Is What Whales Are Betting On Gilead Sciences
July 25, 2024
Via
Benzinga
Four Stocks To Watch This Week - Monday, August 5
August 05, 2024
Via
Talk Markets
2 Unstoppable Dividend Stocks to Buy if There's a Stock Market Sell-Off
August 03, 2024
Via
The Motley Fool
Q3’s Rising Stars: 3 Nasdaq Stocks for Your Must-Watch List
August 02, 2024
Via
InvestorPlace
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
August 02, 2024
Via
Benzinga
The Top 3 Biotech Stocks to Buy Now Summer 2024
July 31, 2024
Via
InvestorPlace
Kazia Therapeutics Stock: Is KZIA a Buyout Candidate in the Making?
July 31, 2024
Via
InvestorPlace
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend Yields
July 29, 2024
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
July 26, 2024
Via
Benzinga
Nasdaq 100 Falls To 7-Week Lows, Marks Worst 2-Day Drop In Nearly 2 Years As Tech Rout Rages On
July 25, 2024
Via
Benzinga
Gilead Sciences to Release Second Quarter 2024 Financial Results on Thursday, August 8, 2024
July 25, 2024
From
Gilead Sciences, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Privacy Policy
|
Terms of Use
|
MNG Corporate Site Map
|
Copyright